Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Priming agents transiently reduce the clearance of cell-free DNA to improve liquid biopsies
Carmen Martin-Alonso, Shervin Tabrizi, Kan Xiong, et al.
Science (2024) Vol. 383, Iss. 6680
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Nanozymes for nanohealthcare
Yihong Zhang, Gen Wei, W. Liu, et al.
Nature Reviews Methods Primers (2024) Vol. 4, Iss. 1
Closed Access | Times Cited: 45
Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery
Ivan V. Zelepukin, Konstantin G. Shevchenko, Sergey M. Deyev
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
An in vitro CRISPR screen of cell-free DNA identifies apoptosis as the primary mediator of cell-free DNA release
Brad A. Davidson, Adam X. Miranda, Sarah C. Reed, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 7
Surpassing sensitivity limits in liquid biopsy
Tina Moser, Ellen Heitzer
Science (2024) Vol. 383, Iss. 6680, pp. 260-261
Closed Access | Times Cited: 6
Proteome Fishing for CRISPR/Cas12a-Based Orthogonal Multiplex Aptamer Sensing
Shuangqin Li, Baichuan Jin, Yintao Ma, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 29, pp. 19874-19885
Closed Access | Times Cited: 6
Impact of Higher Cell-Free DNA Yields on Liquid Biopsy Testing in Glioblastoma Patients
J. Bryan Iorgulescu, Timothy Blewett, Kan Xiong, et al.
Clinical Chemistry (2025) Vol. 71, Iss. 1, pp. 215-225
Closed Access
Current advances and future prospects of blood-based techniques for identifying benign and malignant pulmonary nodules
Xin Wang, Yanmei Chen, Chengcheng Ma, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 207, pp. 104608-104608
Closed Access
Exercise intensity and training alter the innate immune cell type and chromosomal origins of circulating cell-free DNA in humans
Kameron B. Rodrigues, Ziming Weng, Zachary Graham, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 3
Open Access
Circulating tumour DNA in early stage and locally advanced NSCLC: ready for clinical implementation?
Nicola Normanno, Alessandro Morabito, Anna Maria Rachiglio, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access
Detection of mutated KRAS, TP53, CDK2A, and SMAD4 in tumor cell-free DNA of Brazilian pancreatic adenocarcinoma patients using next-generation sequencing
Anelis Maria Marin, Branca Engel Timoner, Diogo Dias Araújo, et al.
Research Square (Research Square) (2025)
Open Access
Are Non-invasive Multi-cancer Early Cancer Detection Tests the Future?
William M. Grady
Digestive Diseases and Sciences (2025)
Closed Access
Aptamer-based electrochemical analysis platform for tumor cells and biomarkers detection
Yihan Wang, Wenyan Yao, Wenyu Sun, et al.
Journal of Electroanalytical Chemistry (2024) Vol. 960, pp. 118194-118194
Closed Access | Times Cited: 4
Aggregation-Induced Emission Luminogen: Role in Biopsy for Precision Medicine
Yanhong Duo, Lei Han, Yaoqiang Yang, et al.
Chemical Reviews (2024) Vol. 124, Iss. 20, pp. 11242-11347
Open Access | Times Cited: 4
The role of biomarkers in the early detection of pancreatic cancer
Michael Goggins
Familial Cancer (2024) Vol. 23, Iss. 3, pp. 309-322
Open Access | Times Cited: 3
Molecular-Sieving Label-Free Surface-Enhanced Raman Spectroscopy for Sensitive Detection of Trace Small-Molecule Biomarkers in Clinical Samples
Mingyang Chen, Yangcenzi Xie, Ming Li
Nano Letters (2024) Vol. 24, Iss. 37, pp. 11520-11528
Closed Access | Times Cited: 3
Improving liquid biopsy for cancer detection
Sarah Crunkhorn
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 3, pp. 174-174
Closed Access | Times Cited: 2
Circulating tumor DNA in liquid biopsy: Current diagnostic limitation
Shicai Liu
World Journal of Gastroenterology (2024) Vol. 30, Iss. 15, pp. 2175-2178
Open Access | Times Cited: 2
GWAS shows the genetics behind cell-free DNA and highlights the importance of p.Arg206Cys in DNASE1L3 for non-invasive testing
Jasper Linthorst, Michel G. Nivard, Erik A. Sistermans
Cell Reports (2024) Vol. 43, Iss. 10, pp. 114799-114799
Open Access | Times Cited: 2
Minimal residual disease as a target for liquid biopsy in patients with solid tumours
Klaus Pantel, Catherine Alix‐Panabières
Nature Reviews Clinical Oncology (2024) Vol. 22, Iss. 1, pp. 65-77
Closed Access | Times Cited: 2
Addendum and Non-invasive Multiregion, Multisample Tumor Sequencing
Michael Renteln
(2024)
Open Access | Times Cited: 1
A New Paradigm in Cancer Treatment: Identifying and Targeting Clonal Mutations
Michael Renteln
(2024)
Open Access | Times Cited: 1
Red blood cells function as reservoirs of tumor DNA
Jeffrey C. Thompson, Sue Li, Joshua S. Jose, et al.
AJP Lung Cellular and Molecular Physiology (2024) Vol. 326, Iss. 5, pp. L646-L650
Closed Access | Times Cited: 1
A New Paradigm in Cancer Treatment: Identifying and Targeting Clonal Mutations
Michael Renteln
(2024)
Open Access | Times Cited: 1
A New Paradigm in Cancer Treatment: Identifying and Targeting Clonal Mutations
Michael Renteln
(2024)
Open Access | Times Cited: 1
Decoding the Dynamics of Circulating Tumor DNA in Liquid Biopsies
Khadija Shahab Turabi, Kelsey Klute, Prakash Radhakrishnan
Cancers (2024) Vol. 16, Iss. 13, pp. 2432-2432
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top